Close Menu

MilliporeSigma

NEW YORK (GenomeWeb News) – Myriad Genetics said this week that BioMarin Pharmaceutical will use its BRACAnalysis test in its pivotal Phase 3 clinical study for BMN 673, an orally active PARP-inhibitor designed to induce synthetic lethality in BRCA-deficient cells.

NEW YORK (GenomeWeb News) – Sigma Life Science has reached a deal to license its CompoZr Zinc Finger Nuclease technology to Horizon Discovery on a non-exclusive basis, Sigma-Aldrich announced today.

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported a 3 percent increase year over year in its second-quarter revenues as the company beat consensus analyst estimates on the top and bottom lines.

Gyros this week announced a partnership with EMD Millipore to develop, manufacture, and commercialize immunoassay kits for the Gyrolab platform.

NEW YORK (GenomeWeb News) – Sigma-Aldrich today said it is partnering with the Scripps Research Institute to develop and commercialize new reagents.

As the protease most commonly used to digest proteins into peptides for mass spec analysis, trypsin is a key part of most proteomic workflows, with the performance of the enzyme potentially affecting a variety experimental outcomes including sequence coverage and reproducibility.

DNAnexus has launched a developer program that offers bioinformaticians and software engineers the technical and support resources needed to create and integrate data analysis applications on its platform.

Roche this week launched new software updates, including advanced high-resolution melting analysis and qualitative detection modules, for the LightCycler 96 system.

NEW YORK (GenomeWeb News) – Cellular Dynamics today said that it has licensed certain genetic engineering patents from Life Technologies and Sigma-Aldrich, which the Madison, Wis.-based firm will use in creating human disease models and isogenic controls.

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Tuesday it has extended its global supply and distribution agreement with EMD Millipore.

Pages

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.